TCA Cycle and Mitochondrial Respiration Readouts

Turnover, electron transport, gradient and ATP synthesis are four measurements.

Four Measurements That Are Not Interchangeable

MeasurementWhat it reportsRepresentative method
TCA turnoverCarbon flux through the cycle¹³C substrate tracing with isotopologue analysis
Electron transport rateOxygen consumption by the chainOCR, in intact or permeabilised cells
Proton gradientMembrane potential or ΔpHFluorescent dyes or electrode-based estimates
ATP synthesisMitochondrial ATP productionATP-linked respiration, or ATP measurement with inhibitors

A cell can increase TCA turnover without increasing electron transport (if more carbon exits as citrate), or increase electron transport without increasing ATP synthesis (if the chain is uncoupled by proton leak). Reporting "mitochondrial function increased" from any single row is the most common overreach in this area.

Readout note. OCR is the rate of oxygen consumption under the assay's conditions. It depends on the substrate supplied, the cell density, the buffer and the temperature. It is not ATP production, and it is not a measure of mitochondrial mass — a point that matters because mitochondrial content changes with treatment, and OCR normalised to cell number will then track content as much as function.

Part 1 — Readouts by Question

QuestionBest available approachCaveat
Is the cycle turning over?¹³C-glucose or ¹³C-glutamine, citrate/α-ketoglutarate/malate isotopologuesTurnover and pool size both affect labelling; needs modelling for rates
Is the chain active?Basal OCR in defined substrate conditionsSubstrate mix, not the chain, is often limiting
How much capacity is there?Maximal OCR after titrated uncouplerOver-titration damages membranes; single-concentration conventions are unreliable
How much is used for ATP?Oligomycin-sensitive OCR, with a stated calculationAssumes complete ATP synthase inhibition
Is the chain intact?Substrate-specific respiration in permeabilised cellsRequires digitonin titration; over-permeabilisation loses cytochrome c
Is the gradient maintained?Dye-based potential measurementDye distribution depends on potential itself; quantitation is difficult

The fourth row deserves emphasis. "ATP-linked respiration" is a derived quantity: it is the difference between a basal rate and a post-oligomycin rate, and it inherits the assumptions of both. Reporting the derived value without the raw rates makes the calculation unauditable.

Part 2 — Substrate-Specific Respiration

The most informative mitochondrial assay in current use is substrate-specific respiration in permeabilised cells, because it controls the substrate rather than the cell.

Substrate combinationRoute testedCommon purpose
Pyruvate + malateComplex I via PDHPDH-axis and complex I capacity
Glutamate + malateComplex I, bypassing PDHComplex I independent of pyruvate entry
Succinate + rotenoneComplex IIDistinguishes complex II from complex I
Palmitoyl-carnitine + malateFatty acid oxidationFAO capacity and CPT1 dependence
TMPD + ascorbateComplex IVTerminal capacity

Two technical requirements determine whether the data mean anything. Digitonin must be titrated for each cell type: too little leaves membranes intact and the substrates do not reach the matrix; too much permeabilises the outer membrane and cytochrome c leaks out, collapsing complex IV capacity. The assay medium must be defined, because the same cells give different maximal rates in different buffer compositions.

Part 3 — Isotope Tracing for the Cycle

ObservationCommon interpretationAlternative to exclude
Citrate m+2 from [U-¹³C]glucoseOne PDH turn plus one cycle turnPyruvate cycling dilutes label
Citrate m+3, m+4Pyruvate carboxylation or multiple turnsPool heterogeneity; needs modelling
Succinate and fumarate labelling asymmetryCycle turnover and exchange with the poolReversal of succinate dehydrogenase under some conditions
Glutamine-derived malate and citrateAnaplerosis and reductive carboxylationCompartment mixing in bulk extracts

Important distinction. Isotopologue patterns report the routes by which carbon arrived; they do not report the rate. Converting labelling into flux requires extracellular rates for the substrates, a network model and a fit assessment — the standard ¹³C-metabolic flux analysis workflow. Without those, the output is a routing statement.

A second distinction matters for the cycle specifically: anaplerosis and cataplerosis are not visible in pool sizes. Glutamine can be feeding the cycle steadily while total citrate is unchanged, because efflux to lipid synthesis balances influx. Only tracing (or a mass-balance design) reveals the traffic.

Part 4 — The Inhibitor Panel and Its Assumptions

AgentTargetAssumption it relies on
OligomycinATP synthaseComplete inhibition at the concentration used
FCCP or BAM15UncouplerTitrated to maximal respiration without damage; not assumed
RotenoneComplex IComplete block; effective in the cell type used
Antimycin AComplex IIIComplete block
TTFAComplex IISpecificity at the concentration used
3-nitropropionateSuccinate dehydrogenaseIrreversible; recovery requires new enzyme

Caveat on single-concentration conventions. The widely used sequence (oligomycin, then uncoupler, then rotenone plus antimycin A) yields interpretable parameters only if each agent is at an effective and non-toxic concentration. A titration of the uncoupler in the same plate is worth the wells: it converts "maximal respiration" from a convention into a measurement, and it reveals toxicity that a fixed dose conceals.

A second caveat: several of these agents are dissolved in ethanol or DMSO, and the vehicle effects on respiration are not negligible at the volumes used in small wells. Vehicle controls belong in the plate, not in the methods section.

Part 5 — Three Levels of Evidence

LevelClaimMinimum evidenceWhat does not count
1. ActivityOxygen consumption changedNormalised OCR in defined substrate conditions, with raw ratesRaw plate values; a single well
2. Capacity or routeA specific complex or substrate route changedSubstrate-specific respiration in permeabilised cells, or a titrationBasal OCR alone
3. DependenceThe change is required for a phenotypePerturbation of the relevant complex or transporter, with rescue, under a constraintCorrelation between OCR and growth

Part 6 — Model and Assay Requirements

RequirementWhy
Defined assay mediumSubstrate composition sets basal rate
Digitonin titration, if permeabilisedOtherwise substrates do not reach the matrix, or cytochrome c is lost
Uncoupler titrationConverts maximal respiration into a measurement
Plate layout without edge effectsEvaporation changes rates in perimeter wells
Normalisation basis statedViable count, DNA or protein; each has limitations
Mitochondrial content measuredSeparates content from function
Temperature and mixing controlledBoth affect oxygen diffusion and consumption

Part 7 — Failures That Recur

  • • Basal OCR reported as mitochondrial function, without substrate or normalisation context.
  • • Maximal respiration from a single uncoupler concentration.
  • • Permeabilised-cell data without a digitonin titration, or without a cytochrome c check.
  • • "ATP-linked respiration" reported without the raw rates used to derive it.
  • • Mitochondrial mass and mitochondrial function conflated. Content should be measured (mtDNA, a complex subunit, or fluorescence) alongside the rate.
  • • Isotopologue patterns reported as fluxes.
  • • Vehicle effects omitted for ethanol- or DMSO-dissolved inhibitors.
  • • Edge wells included in a plate-based assay without a layout control.

Part 8 — Where This Article Connects

This article supplies the mitochondrial half of the pillar's flux question. The glycolysis–OXPHOS switch article defines partition; this one defines what the oxidative side can and cannot measure. The Seahorse protocol articles that follow in this cluster handle instrument parameters and baseline troubleshooting, which are assay-execution problems rather than interpretation problems.

If you need substrate-specific respirometry with digitonin and uncoupler titration built in, we can scope the design with you.

Contact EDITGENE to request a project consultation or quote.

Scientific scope and validation note

Respiratory capacity, substrate preference and coupling efficiency vary with cell type, medium, passage and assay conditions; the values implied by these methods are assay-dependent, not absolute properties of the cell.

A change in oxygen consumption does not establish a change in ATP synthesis, and a change in ATP synthesis does not establish a change in TCA turnover.

Scientific interpretation and experimental design

  • • Four measurements, four questions. Turnover, transport, gradient, synthesis.
  • • OCR is not mass. Measure content when the treatment could change it.
  • • Titrate the uncoupler. A fixed dose is a convention, not a measurement.
  • • Titrate digitonin. Both under- and over-permeabilisation produce plausible wrong answers.
  • • Derived values need raw rates. Otherwise the calculation cannot be checked.
  • • Labelling is routing. Flux requires extracellular rates and a model.

Selected references for further reading

  • • Brand MD, Nicholls DG. Assessing mitochondrial dysfunction in cells. Biochemical Journal. 2011;435:297–312.
  • • Divakaruni AS, Jastroch M. A practical guide for the analysis, standardization, and interpretation of oxygen consumption measurements. Nature Metabolism. 2022;4:978–994.
  • • Buescher JM, et al. A roadmap for interpreting ¹³C metabolite labeling patterns from cells. Current Opinion in Biotechnology. 2015;34:189–201.
  • • Antoniewicz MR. A guide to ¹³C metabolic flux analysis for the cancer biologist. Experimental & Molecular Medicine. 2018;50:1–13.

Related Products

Product name Cat.No. Species Gene ID
PBRM1 Knockout A-549 Cell Line EDJ0001-K01 Human 55193 Details Get a Quote
YTHDC1 Knockout A-549 Cell Line EDC07652 Human 91746 Details Get a Quote
TP53 Knockout HCT 116 Cell Line EDC07854 Human 7157 Details Get a Quote
Sirt2 Knockout MH-S Cell Line EDJ-KQ78173 Mouse 64383 Details Get a Quote
TFE3 Knockout KGN Cell Line EDJ-KQ48 Human 7030 Details Get a Quote
Stub1 Knockout MB49 Cell Line EDJ-KQ53 Mouse 56424 Details Get a Quote
ARID1A Knockout SNK-6 Cell Line EDJ-KQ64 Human 8289 Details Get a Quote
Tet1 Knockout Kupffer Cell Line EDJ-KQ88 Mouse 52463 Details Get a Quote
NR1H3 Knockout HEK293T Cell Line EDJ-KQ109 Human 10062 Details Get a Quote
NR1H2 Knockout HEK293T Cell Line EDJ-KQ110 Human 7376 Details Get a Quote
RPS6KB2 Knockout HEK293 Cell Line EDJ-KQ125 Human 6199 Details Get a Quote
SMAD6 Knockout HEK293 Cell Line EDJ-KQ126 Human 4091 Details Get a Quote
JUN Knockout HEK293 Cell Line EDJ-KQ176 Human 3725 Details Get a Quote
JUN Knockout HEK293T Cell Line EDJ-KQ184 Human 3725 Details Get a Quote
ALKBH5 Knockout HEK293 Cell Line EDJ-KQ186 Human 54890 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: